IBRX

ImmunityBio, Inc. Common Stock
$7.52 -2.59%

Recent alerts on IBRX

All signals →
News ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug
13d ago
News ImmunityBio rises as Anktiva label expansion undergoes FDA review
13d ago
News ImmunityBio Says ANKTIVA Combo Outperformed Rival Bladder Cancer Therapies
13d ago
SEC filing IBRX Signs Exclusive U.S. Agreement with Japan BCG Laboratory for Tokyo Strain BCG, Backed by Positive Phase III SWOG S1602 Trial Results
14d ago
News ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership
15d ago
News ImmunityBio acquiring U.S. rights to Tokyo strain of BCG
16d ago
News Semiconductor materials and biotech stocks drive mid‑cap YTD rally
18d ago
SEC filing IBRX Reports $44.2M Net Product Revenue, +168% YoY; $380.9M Cash; ANKTIVA Expands to 5 Jurisdictions, BCG-Naïve Trial Enrolled, NCCN Guideline Update
26d ago
News Avis Brings Back The Short Squeeze — Navitas, Beyond Meat Join In
41d ago
News FDA Flags Anktiva Claims While ImmunityBio Pushes Regulatory Fixes
56d ago
News ImmunityBio Plunges After Getting FDA Warning on Cancer Drug
70d ago
News Why ImmunityBio Stock Is Up More Than 11% Today
70d ago
News ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use
76d ago
News ImmunityBio gains as NCCN guidelines include new Anktiva indication
77d ago
News ImmunityBio rises after updates on cell therapy programs
80d ago
News Why Is ImmunityBio Stock Soaring On Friday?
81d ago
News ImmunityBio Q4 2026 Earnings Preview
91d ago
Insider trade Sale by Simon Barry J.
95d ago
News ImmunityBio Investors Rally Behind Cancer Trial Milestone
95d ago
News ImmunityBio GAAP EPS of -$0.06, revenue of $38.2M
99d ago
News Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer
103d ago
SEC filing IBRX Announces EC Conditional Authorization for ANKTIVA+BCG in NMIBC CIS, 71% CR, 33 Countries
104d ago
Insider trade Sale by Christobel Selecky
104d ago
Insider trade Sale by Simon Barry J.
104d ago
News New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
104d ago

Get push alerts for IBRX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS